Equillium Inc (NASDAQ: EQ) on Tuesday, plunged -17.83% from the previous trading day, before settling in for the closing price of $1.57. Within the past 52 weeks, EQ’s price has moved between $0.27 and $2.35.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 31.13%. The company achieved an average annual earnings per share of -86.96%. With a float of $43.57 million, this company’s outstanding shares have now reached $60.68 million.
Equillium Inc (EQ) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Equillium Inc is 28.45%, while institutional ownership is 48.39%. The most recent insider transaction that took place on Dec 23 ’25, was worth 150,000. In this transaction Sr. Vice President and COO of this company sold 100,000 shares at a rate of $1.50, taking the stock ownership to the 91,444 shares. Before that another transaction happened on Dec 23 ’25, when Company’s Officer proposed sale 100,000 for $1.50, making the entire transaction worth $150,000.
Equillium Inc (EQ) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.16 earnings per share (EPS) for the period topping the consensus outlook (set at -0.31) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -86.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.47% during the next five years compared to 31.13% growth over the previous five years of trading.
Equillium Inc (NASDAQ: EQ) Trading Performance Indicators
Equillium Inc (EQ) is currently performing well based on its current performance indicators. A quick ratio of 10.85 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Equillium Inc (EQ)
Compared to the last year’s volume of 0.82 million, its volume of 1.0 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 48.90%.
During the past 100 days, Equillium Inc’s (EQ) raw stochastic average was set at 33.49%, which indicates a significant decrease from 37.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2014 in the past 14 days, which was higher than the 0.1814 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1776, while its 200-day Moving Average is $0.8966. Nevertheless, the first resistance level for the watch stands at $1.4933 in the near term. At $1.6967, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8033. If the price goes on to break the first support level at $1.1833, it is likely to go to the next support level at $1.0767. Now, if the price goes above the second support level, the third support stands at $0.8733.
Equillium Inc (NASDAQ: EQ) Key Stats
Market capitalization of the company is 78.55 million based on 60,893K outstanding shares. Right now, sales total 41,100 K and income totals -8,070 K. The company made 0 K in profit during its latest quarter, and -4,230 K in sales during its previous quarter.
